Diaphragm Pacing Therapy System Market to Grow with a CAGR of 4.06% through 2028
Increasing prevalence of respiratory disorders and the
promise of a significantly improved quality of life is expected to drive the
Global Diaphragm Pacing Therapy System Market growth in the forecast period,
2024-2028.
According to TechSci Research report, “Diaphragm
Pacing Therapy System Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2028”, the Global Diaphragm
Pacing Therapy System Market stood at USD 7.71 billion in 2022 and is
anticipated to grow with a CAGR of 4.06% in the forecast period, 2024-2028.
This can be attributed to technological advancements. Advancements in medical
technology have played a pivotal role in the growth of this market. Modern
diaphragm pacing therapy systems are equipped with cutting-edge features, such
as longer battery life, smaller and more comfortable devices, wireless
connectivity for remote monitoring, and improved user interfaces. These
innovations make the systems more convenient for patients and healthcare
providers, leading to increased adoption.
Furthermore, the focus on patient-centered care is
gaining momentum in healthcare, and it is becoming a key trend in the diaphragm
pacing therapy system market. Tailoring therapy to individual patient needs and
preferences is essential. This includes customizing device settings, optimizing
therapy regimens, and providing comprehensive patient education and support.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Diaphragm
Pacing Therapy System Market.”
The market is expected to experience growth due to the
increasing prevalence of conditions such as sleep apnea, amyotrophic lateral
sclerosis, and spinal cord injuries. The diaphragm pacemaker offers advantages
in terms of accuracy and comfort when compared to mechanical ventilators, while
also reducing the risk of upper airway infections like ventilator-associated
pneumonia. Favorable regulatory policies and approvals are further driving the
adoption of diaphragm pacing therapy systems.
Moreover, the demand for these systems saw a
significant uptick during the COVID-19 pandemic as they became crucial in
meeting the increased need for respiratory care in infected patients. Diaphragm
pacing therapy systems reduce the reliance on mechanical ventilators, and many
patients prefer them due to their ability to facilitate natural breathing,
improve speech patterns, enhance the sense of smell, and make eating and
drinking more convenient. The quiet and mobile operation of these breathing
pacemakers, as well as their compact size, are also expected to further boost
their adoption.
The Global Diaphragm Pacing Therapy System Market is
segmented into product, application, regional distribution, and company.
Based on its product, the external diaphragm pacemaker
category held a leading position in the market in 2022, representing the
highest share of revenue.
This segment has been experiencing increased
recognition due to the growing demand for treating conditions like cervical
spinal cord injury and congenital central hypoventilation syndrome. The
diaphragm pacemaker addresses concerns related to power interruptions and the
need for an external power source. Additionally, its mobility and noiseless
operation contribute to the expansion of the market.
Based on application, the spinal cord injury sector
emerged as the dominant force in the market in 2022, contributing the largest
share of revenue. This was primarily due to the increasing global incidence of
spinal cord injuries, which is exemplified by statistics from the National
Spinal Cord Injury Statistical Center reporting around 17,000 new cases
annually in the United States.
Furthermore, the rising occurrences of accidents,
falls, and sports/recreation-related injuries have propelled the prevalence of
spinal cord injuries, resulting in a higher number of patients seeking
diaphragm pacing therapy systems. Additionally, the expanding prevalence of
amyotrophic lateral sclerosis is expected to further drive the market for
diaphragm pacing therapy systems. This condition is most frequently observed in
the elderly population, with approximately 5,000 new cases diagnosed each year
in the U.S.
Major companies operating in Global Diaphragm
Pacing Therapy System Market are:
- LUNGPACER MEDICAL INC.
- Avery Biomedical Devices, Inc.
- Synapse Biomedical Inc
- Astrotech Corp
Download
Free Sample Report
Customers can also request for 10%
free customization on this report.
“The future of the Global Diaphragm Pacing Therapy System
Market is teeming with potential as the key trends shape its landscape. With
advancements in device technology, an expansion of applications, and a growing
focus on data-driven and patient-centered care, diaphragm pacing therapy
promises to revolutionize the treatment of respiratory disorders. As awareness,
regulatory support, and collaboration grow, the global healthcare community is
poised to provide better, more accessible care to those in need of diaphragm
pacing therapy,” said Mr. Karan Chechi, Research Director with TechSci
Research, a research-based management consulting firm.
“Diaphragm Pacing Therapy System Market By
Product (External Diaphragm Pacemaker, Diaphragm
Pacemaker), By Application (Spinal Cord Injury, Amyotrophic Lateral Sclerosis,
Others), By
Region, By Competition Forecast
& Opportunities, 2018-2028F”, has evaluated the future growth potential of Global
Diaphragm Pacing Therapy System Market and provides statistics &
information on market size, structure and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global Diaphragm Pacing Therapy System Market.
Contact
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com